Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
Clinical trial NCT00258349 · COMPLETED
Trial details
- NCT number
- NCT00258349
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2010-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.